Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
about
Reevaluating Cumulative HIV-1 Viral Load as a Prognostic Predictor: Predicting Opportunistic Infection Incidence and Mortality in a Ugandan Cohort.Repeated administration of high-dose depot medroxyprogesterone acetate does not alter SHIVSF162p3 viral kinetics and tenofovir pharmacokinetics when delivered via intravaginal rings.Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.
P2860
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
@ast
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
@en
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years.
@nl
type
label
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
@ast
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
@en
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years.
@nl
prefLabel
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
@ast
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
@en
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years.
@nl
P2093
P2860
P356
P1476
Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years
@en
P2093
Joel Singer
Juan Sierra-Madero
Mark W Hull
Paul Richard Harrigan
Viviane D Lima
P2860
P356
10.7448/IAS.17.1.18617
P577
2014-05-06T00:00:00Z